In a significant move to revolutionize maternal and child health in India, Reckitt, a leading global consumer health and hygiene company,has partnered with PATH, a global nonprofit organization, and Centre for Health Research and Innovation (CHRI), to launch the Dettol Banega Swasth India – Maternal and Child Health Tech Accelerator.
This initiative is a call to action for India’s brightest innovators to reimagine healthcare for mothers and children, especially in underserved communities. With focus on early health and development interventions during the first 1000 days of life, the accelerator will serve as a platform to identify and support innovative solutions that empower mothers and caregivers, frontline workers, and health systems to deliver better outcomes from the very start of life. It also aims to strengthen the public health ecosystem across 500 aspirational blocks of India, ensuring that innovation truly benefits those who need it most.
Through this initiative, Reckitt and PATH-CHRI are inviting innovators from India with product-ready solutions (TRL 9). Shortlisted innovators will take center stage at a high-impact pitch event on 15th and 16th September, where they will showcase their solutions to an eminent jury panel comprising leaders from across the health sector — including Padma Shri awardees in public health, policy experts, and grassroots changemakers.
The top five winning innovations will be awarded on 2nd October, during the grand launch of Dettol Banega Swasth India Season 12, a platform that has become synonymous with health transformation in India. But the journey doesn’t end there. These five solutions will be implemented in partnership with Plan India, with the goal to support mothers and caregivers during the first 1000 days, empower frontline health workers and improve maternal and child health outcomes, especially in marginalized and underserved communities.
